Perbedaan Nusantara Sawit Sejahtera Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Nusantara Sawit Sejahtera Tbk. diperdagangkan di Rp765 (kapitalisasi pasar 17,97 T, volume 24 jam 6,13 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb). Perbedaan utamanya: Nusantara Sawit Sejahtera Tbk. jauh lebih besar — sekitar 104× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Nusantara Sawit Sejahtera Tbk. lebih aktif diperdagangkan (6,13 jt vs 592,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| NSSS | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 17,97 T | 172,82 M |
Volume | 6,13 jt | 592,2 rb |
Lot | 61,34 rb | 5,92 rb |
Perputaran | 4,66 M | 147,05 jt |
Harga Rata-rata | 759,29 | 248,31 |
Nilai Transaksi | 4,66 M | 147,05 jt |
Harga Ekuilibrium Indikatif | 765 | 254 |
Volume Ekuilibrium Indikatif | 1,12 rb | 10 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.
Selengkapnya di halaman NSSS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →